The Evaluation of Inflammatory Activity in Rheumatoid Arthritis by Using Fludeoxyglucose (18F)
Not Applicable
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000000716
- Lead Sponsor
- Department of Allergy and Rheumatology and Department of Radiology, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patient who fulfills one of the following criteria must be excluded: 1) coexistence of arthropathy other than RA 2) complicated by clinically apparent infection or vasculitis 3) blood glucose more than 150mg/dL at the administration of 18F-FDG 4) under administration of infusion which contains glucose, or on insulin treatment 5) female patient during pregnancy or lactation 6) contraindicated for MRI 7) contraindicated for contrast-material infusion in MRI 8) judged to be inappropriate by the principal investigator or subinvestigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical evaluation of RA (physical examination and laboratory data), the findings of synovitis in hand MRI with contrast, and the SUV in FDG-PET (adjusted by weighting at each joint)
- Secondary Outcome Measures
Name Time Method